PointState Capital’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-154,000	Closed	-$4.38M	–	149
2018 Q1	$4.38M	Buy	+154,000	New	+$4.38M	0.05%	103